225 related articles for article (PubMed ID: 23329653)
1. Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T.
Nagel KN; Schouten MG; Hambrock T; Litjens GJ; Hoeks CM; ten Haken B; Barentsz JO; Fütterer JJ
Radiology; 2013 Apr; 267(1):164-72. PubMed ID: 23329653
[TBL] [Abstract][Full Text] [Related]
2. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
4. Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience.
Zhang J; Tehrani YM; Wang L; Ishill NM; Schwartz LH; Hricak H
Radiology; 2008 May; 247(2):458-64. PubMed ID: 18430878
[TBL] [Abstract][Full Text] [Related]
5. Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
Somford DM; Hambrock T; Hulsbergen-van de Kaa CA; Fütterer JJ; van Oort IM; van Basten JP; Karthaus HF; Witjes JA; Barentsz JO
Invest Radiol; 2012 Mar; 47(3):153-8. PubMed ID: 22293513
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer.
Somford DM; Hoeks CM; Hulsbergen-van de Kaa CA; Hambrock T; Fütterer JJ; Witjes JA; Bangma CH; Vergunst H; Smits GA; Oddens JR; van Oort IM; Barentsz JO;
Invest Radiol; 2013 Mar; 48(3):152-7. PubMed ID: 23328910
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging in the prostate transition zone: histopathological validation using magnetic resonance-guided biopsy specimens.
Hoeks CM; Vos EK; Bomers JG; Barentsz JO; Hulsbergen-van de Kaa CA; Scheenen TW
Invest Radiol; 2013 Oct; 48(10):693-701. PubMed ID: 23614975
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
[TBL] [Abstract][Full Text] [Related]
9. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.
Rosenkrantz AB; Sigmund EE; Johnson G; Babb JS; Mussi TC; Melamed J; Taneja SS; Lee VS; Jensen JH
Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312
[TBL] [Abstract][Full Text] [Related]
11. Interpatient variation in normal peripheral zone apparent diffusion coefficient: effect on the prediction of prostate cancer aggressiveness.
Litjens GJ; Hambrock T; Hulsbergen-van de Kaa C; Barentsz JO; Huisman HJ
Radiology; 2012 Oct; 265(1):260-6. PubMed ID: 22923722
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
[TBL] [Abstract][Full Text] [Related]
13. Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer.
Yu AC; Badve C; Ponsky LE; Pahwa S; Dastmalchian S; Rogers M; Jiang Y; Margevicius S; Schluchter M; Tabayoyong W; Abouassaly R; McGivney D; Griswold MA; Gulani V
Radiology; 2017 Jun; 283(3):729-738. PubMed ID: 28187264
[TBL] [Abstract][Full Text] [Related]
14. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features.
Langer DL; van der Kwast TH; Evans AJ; Plotkin A; Trachtenberg J; Wilson BC; Haider MA
Radiology; 2010 May; 255(2):485-94. PubMed ID: 20413761
[TBL] [Abstract][Full Text] [Related]
15. Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient.
Matoba M; Tonami H; Kondou T; Yokota H; Higashi K; Toga H; Sakuma T
Radiology; 2007 May; 243(2):570-7. PubMed ID: 17400757
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of diffusion-weighted-MRI in prostate cancer.
Wibulpolprasert P; Phongkitkarun S; Chalermsanyakorn P
J Med Assoc Thai; 2013 Aug; 96(8):967-75. PubMed ID: 23991605
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis.
Tamada T; Sone T; Jo Y; Yamamoto A; Yamashita T; Egashira N; Imai S; Fukunaga M
Radiology; 2008 Aug; 248(2):531-9. PubMed ID: 18539890
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of DTI in prostate cancer.
Gürses B; Tasdelen N; Yencilek F; Kılıckesmez NO; Alp T; Fırat Z; Albayrak MS; Uluğ AM; Gürmen AN
Eur J Radiol; 2011 Aug; 79(2):172-6. PubMed ID: 20138721
[TBL] [Abstract][Full Text] [Related]
19. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
20. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A
Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
